CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease von Rennard, Stephen I, Dale, David C, Donohue, James F, Kanniess, Frank, Magnussen, Helgo, Sutherland, E Rand, Watz, Henrik, Lu, Susan, Stryszak, Paul, Rosenberg, Elizabeth, Staudinger, Heribert

Volltext

Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates von Donohue, James F, Jain, Neal

Volltext

Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, ra... von Donohue, James F, Niewoehner, Dennis, Brooks, Jean, O'Dell, Dianne, Church, Alison

Volltext

Improving the Management of COPD in Women von Jenkins, Christine R., MD, Chapman, Kenneth R., MD, Donohue, James F., MD, Roche, Nicolas, MD, Tsiligianni, Ioanna, MD, Han, MeiLan K., MD

Volltext

Another Choice for Prevention of COPD Exacerbations von Donohue, James F

Volltext

FEV1 Minimum Important Difference versus Minimal Detectable Difference? In Search of the Unicorn von Crim, Courtney, Frith, Lucy J., Midwinter, Dawn, Donohue, James F.

Volltext

Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease: Indacaterol Versus Tiotropium von DONOHUE, James F, FOGARTY, Charles, KRAMER, Benjamin, LÖTVALL, Jan, MAHLER, Donald A, WORTH, Heinrich, YORGANCIOGLU, Arzu, IQBAL, Amir, SWALES, James, OWEN, Roger, HIGGINS, Mark

Volltext

Dual-Mode Scramjet Flameholding Operability Measurements von Donohue, James M

Volltext

Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations von Donohue, James F, Worsley, Sally, Zhu, Chang-Qing, Hardaker, Liz, Church, Alison

Volltext

Magnitude of umeclidinium/vilanterol lung function effect depends on monotherapy responses: Results from two randomised controlled trials von Donohue, James F, Singh, Dave, Munzu, Clara, Kilbride, Sally, Church, Alison

Volltext

Current Perspectives of Pharmacotherapies for COPD von Pleasants, Roy A, Donohue, James F

Volltext

Low Doses of Long-Acting β-Agonists/Long-Acting Muscarinic Agents with Large Effects. The FLIGHT Study von Donohue, James F

Volltext

Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis von Jones, Paul W, Donohue, James F, Nedelman, Jerry, Pascoe, Steve, Pinault, Gregory, Lassen, Cheryl

Volltext

Minimal Clinically Important Differences in COPD Lung Function von Donohue, James F.

Volltext

Efficacy and safety of glycopyrrolate/eFlow® CS (nebulized glycopyrrolate) in moderate-to-very-severe COPD: Results from the glycopyrrolate for obstructive lung disease via electro... von Kerwin, Edward, Donohue, James F., Goodin, Thomas, Tosiello, Robert, Wheeler, Alistair, Ferguson, Gary T.

Volltext

The future of chronic obstructive pulmonary disease treatment—difficulties of and barriers to drug development von Martinez, Fernando J, MD, Donohue, James F, MD, Rennard, Stephen I, MD

Volltext

Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective von Singh, Dave, D'Urzo, Anthony D, Donohue, James F, Kerwin, Edward M

Volltext

Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis von Cope, Shannon, Donohue, James F, Jansen, Jeroen P, Kraemer, Matthias, Capkun-Niggli, Gorana, Baldwin, Michael, Buckley, Felicity, Ellis, Alexandra, Jones, Paul

Volltext

The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease von Rennard, Stephen I, Fogarty, Charles, Kelsen, Steven, Long, William, Ramsdell, Joe, Allison, James, Mahler, Donald, Saadeh, Constantine, Siler, Thomas, Snell, Phillip, Korenblat, Phillip, Smith, William, Kaye, Mitchell, Mandel, Michael, Andrews, Charles, Prabhu, Rachakonda, Donohue, James F, Watt, Rosemary, Lo, Kim Hung, Schlenker-Herceg, Rozsa, Barnathan, Elliot S, Murray, John, on behalf of COPD Investigators

Volltext

Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA von Cohen, Joshua S, Miles, Matthew C, Donohue, James F, Ohar, Jill A

Volltext